4.5 Article

Conservative Management for Retained Products of Conception in Late Pregnancy

期刊

HEALTHCARE
卷 11, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/healthcare11020168

关键词

retained products of conception (RPOC); postpartum hemorrhage; human chorionic gonadotropin (hCG)

向作者/读者索取更多资源

This retrospective study compares early manual removal of placenta (MROP) and conservative management of retained products of conception (RPOC) after 34 weeks of gestation. The study found that while both methods had advantages and disadvantages, early MROP led to a shorter time for the placenta to disappear, but also resulted in lower hemoglobin levels after massive bleeding. Randomized controlled trials are necessary to determine the superior treatment option.
This retrospective study aims to compare the early manual removal of placenta (MROP) and conservative management of retained products of conception (RPOC) after 34 weeks of gestation. Nineteen cases underwent MROP within 24 h of delivery, of which nine patients had no symptoms requiring emergent treatment. These 9 patients (group M) were compared with 22 patients who were treated conservatively (group C). Massive bleeding was observed in 5 (56%) patients in group M and 11 (50%) patients in group C, with no significant difference in frequency. However, the lowest hemoglobin level within 72 h after massive bleeding was lower in group M (median: 6.7 vs. 7.7 g/dL, p = 0.029), suggesting that massive bleeding occurred in a short period of time. On the other hand, a retained placenta was observed in four patients in group M after the MROP; however, the placenta disappeared more quickly than in group C (median; 1.0 vs. 99.0 days, p = 0.009). In group C, all bleeding and infection occurred within 60 days of delivery, including heavy bleeding in six cases during the placental-extraction trial. Human chorionic gonadotropin in group C fell below the measurable threshold at a median of 67 days postpartum. In conclusion, for RPOC without urgent symptoms, early MROP and conservative treatment have their advantages and disadvantages. Randomized controlled trials are needed to determine which of those treatments is superior.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据